$29.85
2.40% yesterday
NYSE, May 20, 10:10 pm CET
ISIN
US3580291066
Symbol
FMS

Fresenius Medical Care AG & Co. KGaA Sponsored ADR Stock price

$29.85
+6.33 26.91% 1M
+8.06 36.99% 6M
+7.21 31.85% YTD
+7.92 36.11% 1Y
-0.06 0.20% 3Y
-11.14 27.18% 5Y
-13.59 31.28% 10Y
NYSE, Closing price Tue, May 20 2025
+0.70 2.40%
ISIN
US3580291066
Symbol
FMS
Sector

Key metrics

Market capitalization $17.52b
Enterprise Value $29.27b
P/E (TTM) P/E ratio 26.30
EV/FCF (TTM) EV/FCF 15.88
EV/Sales (TTM) EV/Sales 1.40
P/S ratio (TTM) P/S ratio 0.84
P/B ratio (TTM) P/B ratio 1.13
Dividend yield 2.64%
Last dividend (FY25) $0.79
Revenue growth (TTM) Revenue growth -0.91%
Revenue (TTM) Revenue $20.92b
EBIT (operating result TTM) EBIT $1.68b
Free Cash Flow (TTM) Free Cash Flow $1.84b
Cash position $1.16b
EPS (TTM) EPS $1.13
P/E forward 16.29
P/S forward 0.79
EV/Sales forward 1.31
Short interest 0.20%
Show more

Is Fresenius Medical Care AG & Co. KGaA Sponsored ADR a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,789 stocks worldwide.

Fresenius Medical Care AG & Co. KGaA Sponsored ADR Stock Analysis

Unlock Scores for Free

Analyst Opinions

22 Analysts have issued a Fresenius Medical Care AG & Co. KGaA Sponsored ADR forecast:

8x Buy
36%
9x Hold
41%
5x Sell
23%

Analyst Opinions

22 Analysts have issued a Fresenius Medical Care AG & Co. KGaA Sponsored ADR forecast:

Buy
36%
Hold
41%
Sell
23%

Financial data from Fresenius Medical Care AG & Co. KGaA Sponsored ADR

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
20,922 20,922
1% 1%
100%
- Direct Costs 15,806 15,806
0% 0%
76%
5,117 5,117
5% 5%
24%
- Selling and Administrative Expenses 1,514 1,514
3% 3%
7%
- Research and Development Expense 192 192
21% 21%
1%
3,410 3,410
6% 6%
16%
- Depreciation and Amortization 1,733 1,733
1% 1%
8%
EBIT (Operating Income) EBIT 1,677 1,677
13% 13%
8%
Net Profit 666 666
27% 27%
3%

In millions USD.

Don't miss a Thing! We will send you all news about Fresenius Medical Care AG & Co. KGaA Sponsored ADR directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Fresenius Medical Care AG & Co. KGaA Sponsored ADR Stock News

Neutral
PRNewsWire
15 days ago
Strong organic revenue growth1 of 5% driven by Care Enablement and Care Delivery Stable U.S. same market treatment development despite impact from a severe flu season FME25 savings of EUR 68 million contributed to earnings Operating income2 grew 11% at constant currency resulting in margin expansion Reported operating income grew by 35% and reported net income3 by 113% Net leverage ratio furthe...
Positive
Reuters
15 days ago
World's largest dialysis specialist Fresenius Medical Care reported first-quarter results above analysts' expectations on Tuesday, as revenue grew organically in all its segments, it said.
Neutral
PRNewsWire
2 months ago
In 2024, the operating model to deliver the highest quality of patient care was further optimized by enhancing financial returns, and creating value for shareholders Fresenius Medical Care delivered 18% operating income growth on an outlook base in 2024 Ongoing progress has been achieved in key areas of sustainability: notably in patient care and environmental footprint BAD HOMBURG, Germany , M...
More Fresenius Medical Care AG & Co. KGaA Sponsored ADR News

Company Profile

Fresenius Medical Care AG & Co. KGaA engages in the provision of products and services for patients with chronic kidney failure. It also develop and manufacture a variety of health care products, which includes dialysis and non-dialysis products. The company was founded on August 5, 1996 and is headquartered in Bad Homburg, Germany.

Head office Germany
CEO Helen Giza
Employees 113,840
Founded 1996
Website www.freseniusmedicalcare.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today